fluorouracil has been researched along with dinaciclib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bannerji, R; Jou, YM; Joy, AA; Mita, A; Mita, MM; Sankhala, K; Shapiro, CL; Small, K; Statkevich, P; Yao, SL; Zhang, D; Zhu, Y | 1 |
1 trial(s) available for fluorouracil and dinaciclib
Article | Year |
---|---|
Randomized phase II trial of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus capecitabine in patients with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Capecitabine; Cyclic N-Oxides; Deoxycytidine; Female; Fluorouracil; Humans; Indolizines; Kaplan-Meier Estimate; Middle Aged; Proportional Hazards Models; Pyridinium Compounds | 2014 |